Dosimetric Reference Levels for Radioguided Interventional Procedures in Rhythmology.
NCT ID: NCT06507085
Last Updated: 2024-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
6600 participants
OBSERVATIONAL
2024-05-01
2026-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identification of Risk Factors for the Occurrence of High-grade Rhythm Disorders in Patients With ST-segment Elevation Myocardial Infarction (STEMI)
NCT05040919
Non-invasive Mapping of Rhythm Disorders
NCT02647749
StereoTactic Arrhythmia Radiotherapy in the NetherLands no. 2
NCT05439031
Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation
NCT03453645
Cardiac RadiothErapy for VEntricular Tachycardia
NCT05973578
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To provide healthcare professionals with an optimization tool, the International Commission on Radiological Protection (ICRP) introduced the concept of diagnostic reference levels (DRLs) in 1997. For the first time, in 2019, the French Authority on Nuclear Safety published DRLs for radio-guided interventional practices for 10 interventional radiology procedures and 2 interventional cardiology procedures, based on studies published by the French Society of Medical Physics in collaboration with the French Society of Radiology and the French Coronary Artery Disease and Interventional Cardiology Group. Reference levels for interventional procedudures under CT guidance were also defined in 2020 following a national multicentre study coordinated by Nîmes University Hospital (NIMAO NRD-SI). However, no national multicentre studies have ever defined reference levels for radioguided interventional procedures in rhythmology. The aim of this study is to define standard national diagnostic reference levels for radioguided interventional procedures in rhythmology for the following acts:
* Insertion of a single-chamber pacemaker with lead (DELF 007 according to the common French classification for medical acts)
* Insertion of a dual-chamber pacemaker with lead (DELF 005 according to the common French classification for medical acts)
* Implantation of a multi-site pacemaker (DELF 001 and/or DELF 015 according to the common French classification for medical acts)
* Implantation of a single-chamber endovascular defibrillator (DELF 013 according to the common French classification for medical acts)
* Implantation of a dual-chamber endovascular defibrillator (DELF 015 according to the common French classification for medical acts)
* Placement of multi-site defibrillator (DELF 020 or DELF 014 according to the common French classification for medical acts)
* Typical Primary Atrial Flutter Ablation: Cavotricuspid Isthmus only (DEPF 012 according to the common French classification for medical acts)
* Primo Ablation tachycardia by intra nodal re-entry (DEPF 010 according to the common French classification for medical acts)
* Accessory pathway ablation (DEPF 005 according to the common French classification for medical acts)
* Paroxysmal atrial fibrillation ablation (4 pulmonary veins only, all technologies combined; DEPF 033 as per the common French classification for medical acts)
* Primo Ablation Persistent atrial fibrillation (4 pulmonary veins ± lines ± substrate; DEPF 033 ± DEPF 014 ± DENF 018 ± DEPF 012 according to the common French classification for medical acts) Secondaires objectives include the evaluation of interventional practices for each procedure performed regarding the use of a fixed or mobile C-arm, the make, model and year of installation of the equipment used, deviation at last external quality control between displayed and measured dose area product and, if available, between displayed and measured Kair, the lowest/highest scan rates used during the procedure, use of graphy,lowest/highest scan rate(s) used during procedures, use of collimation during procedures, use of a 3D mapping system, the type of technique used for an ablation procedure, if used, the use of a cage-type radiation protection system during the procedure, cone beam computed tomography performed during procedure, CT scan before the procedure, duration of the procedure and the experience of the operator performing the procedure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients undergoing radio-guided interventional radiology
All patients undergoing interventional radiology to correct heart rhythm disorders
Radio-guided interventions to correct heart rhythm disorders
All patients in the cohort will be undergoing one of the following radio-guided procedures :
* Insertion of a single-chamber pacemaker with lead
* Insertion of a dual-chamber pacemaker with lead
* Implantation of a multi-site pacemaker
* Implantation of a single-chamber endovascular defibrillator
* Implantation of a dual-chamber endovascular defibrillator
* Placement of multi-site defibrillator
* Typical Primary Atrial Flutter Ablation: Cavotricuspid Isthmus only
* Primo Ablation tachycardia by intra nodal re-entry
* Accessory pathway ablation
* Paroxysmal atrial fibrillation ablation (4 pulmonary veins only, all technologies combined
* Primo Ablation Persistent atrial fibrillation (4 pulmonary veins ± lines ± substrate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Radio-guided interventions to correct heart rhythm disorders
All patients in the cohort will be undergoing one of the following radio-guided procedures :
* Insertion of a single-chamber pacemaker with lead
* Insertion of a dual-chamber pacemaker with lead
* Implantation of a multi-site pacemaker
* Implantation of a single-chamber endovascular defibrillator
* Implantation of a dual-chamber endovascular defibrillator
* Placement of multi-site defibrillator
* Typical Primary Atrial Flutter Ablation: Cavotricuspid Isthmus only
* Primo Ablation tachycardia by intra nodal re-entry
* Accessory pathway ablation
* Paroxysmal atrial fibrillation ablation (4 pulmonary veins only, all technologies combined
* Primo Ablation Persistent atrial fibrillation (4 pulmonary veins ± lines ± substrate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body Mass Index (BMI) between 18 and 35 kg/m².
* Patient to benefit from one of the following procedures:
Placement of single-chamber pacemaker with lead (DELF 007 according to CCAM) Dual-chamber pacemaker insertion with lead (DELF 005 according to CCAM) Multi-site pacemaker placement (DELF 001 and/or DELF 015 according to CCAM) Placement of single-chamber endovascular defibrillator (DELF 013 according to CCAM) Placement of dual-chamber endovascular defibrillator (DELF 015 according to CCAM) Placement of multi-site defibrillator (DELF 020 or DELF 014 according to CCAM) Primo Ablation Typical Atrial Flutter: Cavotricuspid Isthmus only (DEPF 012 according to CCAM) Primo Ablation tachycardia by intra nodal re-entry (DEPF 010 according to CCAM) Accessory pathway ablation (DEPF 005 according to CCAM) Paroxysmal atrial fibrillation ablation (4 pulmonary veins only, all technologies combined; DEPF 033 as per CCAM) Primo Ablation Persistent atrial fibrillation (4 pulmonary veins ± lines ± substrate; DEPF 033 ± DEPF 014 ± DENF 018 ± DEPF 012 according to CCAM)
Exclusion Criteria
* Pregnant women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre François Winum, Dr.
Role: PRINCIPAL_INVESTIGATOR
Nîmes University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nîmes University Hospital
Nîmes, Gard, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Joël GREFFIER, Dr.
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Amara W, Socie P, Renault C, Taieb J. [Where are done electrophysiology procedures in France and what is the expected evolution ?]. Ann Cardiol Angeiol (Paris). 2022 Nov;71(5):294-298. doi: 10.1016/j.ancard.2022.08.010. French.
Etard C, Bigand E, Salvat C, Vidal V, Beregi JP, Hornbeck A, Greffier J. Patient dose in interventional radiology: a multicentre study of the most frequent procedures in France. Eur Radiol. 2017 Oct;27(10):4281-4290. doi: 10.1007/s00330-017-4780-5. Epub 2017 Mar 13.
Greffier J, Ferretti G, Rousseau J, Andreani O, Alonso E, Rauch A, Gillet R, Le Roy J, Cabrol-Faivre L, Douane F, David A, Henry S, Jacques T, Stefanovic X, Decoux E, Lafay F, Pilleul F, Couzon F, Boutet C, Woerly B, Baur P, Sans N, Faruch M, Moussier-Lherm A, Tselikas L, Jacquier A, Bigand E, Pessis E, Teriitehau C, Magnier F, Cassagnes L, Haberlay M, Boutteau D, De Kerviler E, Majorel-Gouthain C, Defez D, Vuillod A, Rouviere O, Hennequin L, Fohlen A, Alwan R, Malakhia A, Aubry S, Dohan A, Eresue-Bony M, Gautier R, Dal R, Dabli D, Hebert T, Kovacs R, Hadid-Beurrier L, Bousson V, Potel M, Barbotteau Y, Michel C, Habib-Geryes B, Andre M, Arnaud T, Bestion N, Ernst O, Monfraix S, Brillet PY, Guiu B, Boussel L, Demonchy M, Beregi JP, Frandon J. National dose reference levels in computed tomography-guided interventional procedures-a proposal. Eur Radiol. 2020 Oct;30(10):5690-5701. doi: 10.1007/s00330-020-06903-9. Epub 2020 May 2.
Bar O, Maccia C, Pages P, Blanchard D. A multicentre survey of patient exposure to ionising radiation during interventional cardiology procedures in France. EuroIntervention. 2008 Mar;3(5):593-9. doi: 10.4244/eijv3i5a107.
Radiological protection and safety in medicine. A report of the International Commission on Radiological Protection. Ann ICRP. 1996;26(2):1-47. No abstract available.
Diagnostic reference levels in medical imaging: review and additional advice. Ann ICRP. 2001;31(4):33-52.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIMAO/2023-2/JG-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.